News
Three IDIBELL researchers receive funding from the EU H2020 program
Three IDIBELL researchers have received funding from the European Union to develop research projects within the framework of the Work Program on Health of Social Challenges, in the context of the Horizon 2020 research and innovation program, in its 2019 call. H2020 is an extremely competitive research program, with a strong focus on excellence, innovation […]
The Christmas concert of L’Hospitalet and IDIBELL closes the first edition of the campaign Save lives and the 15th anniversary of the Institute
On December 20th, the Joventut Theater hosted the extraordinary Christmas concert of L’Hospitalet and IDIBELL, starring this year by the Vallès Symphony Orchestra. About 500 spectators enjoyed a show that, as it is traditional, had a solidarity character, since all the raised money will go to biomedical research, specifically, to cancer research projects led by […]
Gabriel Capellá takes stock of the year in the IDIBELL transparency session
IDIBELL has held its annual transparency session, by the director of the institution, Dr. Gabriel Capellá. Before an audience of 170 people, gathered in the Pau Viladiu Conference Hall of the Duran i Reynals Hospital, Capellá has pointed the various items of a detailed and exhaustive report that, in summary, has laid special emphasis on […]
Researchers at ICO and IDIBELL participate in an international study that measures the impact of cervical cancer elimination goals
By 2030, 90% of girls should be vaccinated, 70% of women screened, and 90% of women with precancerous lesions treated
State of ‘hibernation’ keeps haematopoietic stem cells young
All tissues age. The blood-forming system is especially affected by ageing processes. Haematopoietic stem cells, the precursors to blood and immune cells, age exceptionally fast, losing the ability to divide and regenerate. This weakens the immune system and increases the risk of blood cancer. An international team led by researchers from Ulm and Barcelona has […]
An IDIBELL and UB research team demonstrates the involvement of glucose in the growth of tumor cells
Tumors take a great energy expenditure to grow and proliferate. Cancer cells are, in fact, addicted to the main fuel of cellular metabolism, glucose. The molecular machinery that degrades this sugar for energy (the so-called glycolytic enzymes) is overexpressed in tumor cells. But this is not the only characteristic that differentiates the metabolism of tumor […]
IDIBELL and Alba Pérez Foundation take a new step forward to develop a treatment for Ewing’s sarcoma
The Alba Pérez Foundation has signed a framework collaboration agreement with the Bellvitge Biomedical Research Institute that aims to support research projects related to Ewing’s sarcoma, an investigation led by Dr. Òscar Martínez-Tirado, head of IDIBELL’s Sarcomas group. Along the same lines, and making a new step forward, both entities have also signed a specific […]
The researcher Purificación Muñoz receives the V Martí Via prize
Dr. Purificación Muñoz, a researcher at the IDIBELL (Oncobell Program), has been awarded with the V Martí Vía Prize for cancer research, an award given annually by the Vallformosa Foundation and GESCO Family. The grant is endowed with 30,000 euros. This amount is assigned, year after year, to professionals and researchers from areas related to pediatric […]
ICO and IDIBELL researchers study the risk of false positives in colon screening during the period 2000-2017
Screening programs allow to detect the disease when it is in its initial stages to treat it in time and increase the chances of cure. Despite its benefits, there may be a small group of patients who may suffer the consequences of a ‘false positive’, this means that the blood found in the stool may be due to benign pathologies and not cancer.